ILIM
MDCO

Irish Life Investment Managers’s Medicines Co MDCO Stock Holding History

Irish Life Investment Managers’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$63.2K Buy
+2,054
New +$68.7K ﹤0.01% 1199

Other funds holding MDCO

SAC
Smith Affiliated Capital New York $86.5B AUM 5.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Irish Life Investment Managers's MDCO Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Medicines Co (MDCO) in Q2 2013: 2,054 shares worth $63.2K. The stake represents ﹤0.01% of the portfolio and ranks #1199 among its holdings.

168 funds tracked by Wall St. Rank hold MDCO as of Q2 2013.

  • Irish Life Investment Managers held 2,054 shares of Medicines Co worth $63.2K as of Q2 2013.
  • Medicines Co was a new Irish Life Investment Managers position in Q2 2013.
  • Medicines Co made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1199 holding.
  • 168 funds tracked by Wall St. Rank held Medicines Co as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.